Phathom Pharmaceuticals Inc (PHAT) Stock Price, Quote, News & History

PHATNASDAQ
$9.50
0.454.97%
Last update: Sep 4, 7:31 PM
$9.41
0.363.98%

Phathom Pharmaceuticals (PHAT) Stock Price, Quote, News & History | Benzinga

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-36.69M
Investing Cash Flow (TTM)
-219.00K
Financing Cash Flow (TTM)
69.82M
Free Cash Flow (TTM)
-36.91M
Capital Expenditure (TTM)
-219.00K
Net Change in Cash (TTM)
32.91M

Analyst Trends and Forecast

1
Mar
1
Jun
3
Jul
1
Aug
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.9
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$753.19M
PE Ratio (TTM)
-
PE Ratio (FWD)
8.54
PEG Ratio (TTM)
-
PS Ratio (TTM)
2.96
PB Ratio (TTM)
-
Earnings Yield % (TTM)
-13.81%
Earnings Yield % (FWD)
11.71%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
-$4.26

Company Debt

Total Debt
$164.59M
LT Debt
$164.59M
LT Debt Issuance (TTM)
$173.25M
LT Debt Repayment (TTM)
-
Total Cash
$182.48M
Debt to Equity
-
Issuance of Debt (TTM)
-$55.80M
Repayment of Debt (TTM)
-

Key Statistics

Open
$8.99
Close
$9.50
Volume / Avg.
1.24M / 1.26M
Day Range
$8.89 - $9.55
52 Wk Range
8.21 - 18.31
Market Cap
$761.28M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
51
Short Interest
15.32%
Days to Cover
6.87

About

Sector
Health Care
Industry
Pharmaceuticals
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Phathom Pharmaceuticals (PHAT) stock?

A

You can purchase shares of Phathom Pharmaceuticals (NASDAQ:PHAT) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Phathom Pharmaceuticals (PHAT) competitors?

Q

What is the forecast, or price target, for Phathom Pharmaceuticals (PHAT) stock?

A

Phathom Pharmaceuticals has a consensus price target of $18.57.

Q

What is the current price for Phathom Pharmaceuticals (PHAT)?

A

The stock price for Phathom Pharmaceuticals (NASDAQ: PHAT) is $9.41 last updated September 4, 2026 at 7:31 PM EDT.

Q

Does Phathom Pharmaceuticals (PHAT) pay a dividend?

A

There are no upcoming dividends for Phathom Pharmaceuticals.

Q

When is Phathom Pharmaceuticals (NASDAQ:PHAT) reporting earnings?

A

Phathom Pharmaceuticals does not have any upcoming earnings scheduled.

Q

Is Phathom Pharmaceuticals (PHAT) going to split?

A

There is no upcoming split for Phathom Pharmaceuticals.

Q

What sector and industry does Phathom Pharmaceuticals (PHAT) operate in?

A

Phathom Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.